| pubmed-article:14530757 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:14530757 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:14530757 | lifeskim:mentions | umls-concept:C0034721 | lld:lifeskim |
| pubmed-article:14530757 | lifeskim:mentions | umls-concept:C0034693 | lld:lifeskim |
| pubmed-article:14530757 | lifeskim:mentions | umls-concept:C0241669 | lld:lifeskim |
| pubmed-article:14530757 | lifeskim:mentions | umls-concept:C1511529 | lld:lifeskim |
| pubmed-article:14530757 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:14530757 | pubmed:issue | 10 | lld:pubmed |
| pubmed-article:14530757 | pubmed:dateCreated | 2003-10-7 | lld:pubmed |
| pubmed-article:14530757 | pubmed:abstractText | To examine the effects of hypertonic/hyperoncotic treatment on physiologic variables and regional cerebral blood flow and to test its neuroprotective efficiency in a model of permanent venous ischemia. | lld:pubmed |
| pubmed-article:14530757 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14530757 | pubmed:language | eng | lld:pubmed |
| pubmed-article:14530757 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14530757 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:14530757 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14530757 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14530757 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14530757 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14530757 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:14530757 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:14530757 | pubmed:issn | 0090-3493 | lld:pubmed |
| pubmed-article:14530757 | pubmed:author | pubmed-author:TakeshimaTT | lld:pubmed |
| pubmed-article:14530757 | pubmed:author | pubmed-author:KempskiOO | lld:pubmed |
| pubmed-article:14530757 | pubmed:author | pubmed-author:HeimannAA | lld:pubmed |
| pubmed-article:14530757 | pubmed:author | pubmed-author:AlessandroLL | lld:pubmed |
| pubmed-article:14530757 | pubmed:author | pubmed-author:NoppensRR | lld:pubmed |
| pubmed-article:14530757 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:14530757 | pubmed:volume | 31 | lld:pubmed |
| pubmed-article:14530757 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:14530757 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:14530757 | pubmed:pagination | 2495-501 | lld:pubmed |
| pubmed-article:14530757 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:14530757 | pubmed:meshHeading | pubmed-meshheading:14530757... | lld:pubmed |
| pubmed-article:14530757 | pubmed:meshHeading | pubmed-meshheading:14530757... | lld:pubmed |
| pubmed-article:14530757 | pubmed:meshHeading | pubmed-meshheading:14530757... | lld:pubmed |
| pubmed-article:14530757 | pubmed:meshHeading | pubmed-meshheading:14530757... | lld:pubmed |
| pubmed-article:14530757 | pubmed:meshHeading | pubmed-meshheading:14530757... | lld:pubmed |
| pubmed-article:14530757 | pubmed:meshHeading | pubmed-meshheading:14530757... | lld:pubmed |
| pubmed-article:14530757 | pubmed:meshHeading | pubmed-meshheading:14530757... | lld:pubmed |
| pubmed-article:14530757 | pubmed:meshHeading | pubmed-meshheading:14530757... | lld:pubmed |
| pubmed-article:14530757 | pubmed:meshHeading | pubmed-meshheading:14530757... | lld:pubmed |
| pubmed-article:14530757 | pubmed:meshHeading | pubmed-meshheading:14530757... | lld:pubmed |
| pubmed-article:14530757 | pubmed:meshHeading | pubmed-meshheading:14530757... | lld:pubmed |
| pubmed-article:14530757 | pubmed:meshHeading | pubmed-meshheading:14530757... | lld:pubmed |
| pubmed-article:14530757 | pubmed:meshHeading | pubmed-meshheading:14530757... | lld:pubmed |
| pubmed-article:14530757 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:14530757 | pubmed:articleTitle | Effects of hypertonic/hyperoncotic treatment after rat cortical vein occlusion. | lld:pubmed |
| pubmed-article:14530757 | pubmed:affiliation | Institute for Neurosurgical Pathophysiology, Johannes Gutenberg-University Mainz, Germany. | lld:pubmed |
| pubmed-article:14530757 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14530757 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14530757 | lld:pubmed |
